Title : Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.

Pub. Date : 1997 Jun

PMID : 9189130






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 UNLABELLED: The aim of this study was to determine, in a Phase I/II clinical trial, the pharmacokinetics, dosimetry and toxicity, as well as antitumor activity, of the 131I-labeled murine anti-carcinoembryonic antigen (CEA) monoclonal antibody, NP-4 (IgG1 subtype). Iodine-131 CEA cell adhesion molecule 3 Homo sapiens